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Abstract (250 words) 
This study tested the hypothesis that concomitant sympathetic and 
parasympathetic stimulation (“autonomic conflict”) may act as a trigger for 
arrhythmia in long QT syndrome (LQTS). Studies were performed in isolated 
innervated rabbit hearts treated with clofilium (100nmol/L); a potassium 
channel blocker. The influence of vagus nerve stimulation (VNS) on 
spontaneous ventricular arrhythmia was assessed in the absence/presence of 
sustained noradrenaline perfusion (100nmol/L) and with sudden adrenergic 
stress (injections of noradrenaline into the perfusion line). Hearts were 
instrumented for a pseudo-electrocardiogram and monophasic action potential 
recordings. VNS, which slows heart rate, was associated with a stimulation 
frequency-dependent incidence of spontaneous early after-depolarisations 
(EADs) and ventricular tachycardia (VT), best predicted by the duration of the 
electrocardiographic T-wave and by triangulation of the ventricular action 
potential. In the presence of sustained (steady-state) noradrenaline perfusion, 
the incidence of EADs and VT with VNS was decreased from 73/55% to 
45/27%, respectively. However, sudden adrenergic stress, imposed during 
periods of sustained VNS, was associated with a transient increase in the 
incidence of severity of observed arrhythmia, as indicated by an increase in 
the average arrhythmia score (1.6±0.4 vs. 2.1±0.7, p=0.01). Analysis of 
electrophysiological parameters suggests that sudden adrenergic stress is 
associated with a transient prolongation, and increased triangulation, of the 
ventricular action potential, which may predispose to triggered activity. This 
study demonstrates that autonomic conflict is a pro-arrhythmic stimulus in 
LQTS. However, combined adrenergic and parasympathetic stimulation has a 
complex relationship with arrhythmogenicity, with differences in the effects of 
steady-state adrenergic activation vs. sudden adrenergic stress. 
 
Keywords: autonomic conflict; long QT syndrome; torsades de pointes; sympathetic; 
parasympathetic; autonomic nervous system 
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Abbreviations 
EAD early afterdepolarisation 
LQTS long QT syndrome 
TdP torsades de pointes 
TpTe T-wave peak-to-end interval 
VT ventricular tachycardia 
VNS vagus nerve stimulation.  
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1. Introduction 
Malignant ventricular arrhythmias (e.g. torsades de pointes - TdP) are the 
primary cause of syncope and premature death in patients with abnormal 
prolongation of the electrocardiographic QT interval. Despite extensive 
research, the role of the autonomic nervous system in long QT syndrome 
(LQTS) associated arrhythmogenesis is imperfectly understood. The 
conventional textbook picture of the cardiac autonomic control suggests the 
two branches of the autonomic nervous system exert reciprocal actions on the 
heart, such as in the baroreceptor reflex. In reality, this represents an over-
simplification of a system in which simultaneous and synchronous activation 
often occurs.[1-3] For example, during cold-water immersion, activation of the 
parasympathetically mediated mammalian diving reflex and sympathetic / 
adrenergically driven cold-water shock response occurs simultaneously.[1-3] 
 
Cold-water submersion (head under) is known to be a trigger for 
supraventricular and ventricular arrhythmia in young, seemingly healthy 
people, who do not exhibit evidence of arrhythmia at rest.[3-7] These 
arrhythmic events are not commonly observed in the same individuals during 
head out cold-water immersions (sympathetic stimulation, no parasympathetic 
stimulations), or during facial immersion, with breath-hold, which activates the 
parasympathetic diving reflex and not the cold-shock (sympathetic) response. 
This suggests that simultaneous autonomic activation, as in whole-body cold-
water submersion, might be an arrhythmogenic stimulus, and is supported by 
other anecdotal observations,[1] but has never been tested experimentally. 
We recently hypothesised that the sudden and simultaneous sympathetic and 
parasympathetic activity, termed “autonomic conflict”, may be a cause of 
arrhythmia associated with cold-water submersion and more generally in 
situations where autonomic co-activation occurs in conjunction with existing 
predisposing factors.[3] 
 
Post-mortem analysis using DNA sequencing has revealed that nearly 30% of 
the victims of seemingly unexplained drowning have ca rdiac ion channel 
mutations.[8] Moreover, a strong association between swimming and 
arrhythmia/sudden cardiac death has been shown in children with heritable 
LQTS and swimming is recognised as a gene-specific trigger for TdP in 
patients with congenital LQTS type 1.[9-12] Could this represent something 
more than a simple increase in adrenergic tone? Similarly, patients with LQTS 
type 2 generally die during times of sudden stress, such as when awoken by 
an alarm clock, suggesting that it is sympathetic activation during periods of 
high parasympathetic tone that triggers TdP.[10, 13] Evidence from 24-hour 
electrocardiogram recordings in patients with acquired LQTS indicates that 
while prevailing rates are relatively slow, there is a significant increase in 
heart rate in the minutes preceding electrical instability and TdP.[14] 
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Therefore, we propose that the sequence and timing of autonomic activation 
plays a critical role in the induction of LQTS associated arrhythmia. In this 
study, we examined the role of autonomic conflict as a trigger for ventricular 
arrhythmia in conditions of acquired (type 2) LQTS. We hypothesised that 
concomitant sympathetic and parasympathetic stimulation would act as a 
trigger for LQTS associated arrhythmogenesis.  
 
2. Methods 
2.1 Animal welfare 
All procedures were undertaken in accordance with ethical guidelines set out 
by the UK Animals (Scientific Procedures) Act 1986 and Directive 2010/63/EU 
of the European Parliament on the protection of animals used for scientific 
purposes. Studies conformed the Guide for the Care and Use of Laboratory 
Animals published by the U.S. National Institutes of Health under assurance 
number A5634-01. Studies were approved by local ethics review at King’s 
College London. 
 
2.2 Isolated innervated rabbit heart 
All studies uti lised the isolated innervated rabbit heart as described by Ng et 
al, with minor modifications.[10] Experiments were performed in New Zealand 
White Rabbits (2.5-4.5kg). Animals were pre-sedated using a mixture of 
ketamine (Ketaset, 10mg/kg, Fort Dodge, UK), medetomidine hydrochloride 
(Sedator, 0.2mg/kg, Dechra, UK) and butorphanol (Torbugesic, 0.05mg/kg, 
Fort Dodge, UK) (i.m.). Anaesthesia was induced and maintained using 
propofol (5mg as required, Rapinovet, Schering-Plough Animal Health, UK), 
with concomitant heparin (1000 units, Multiparin, UK). Animals were intubated 
and ventilated at 60 breaths per minute of room air. The major blood vessels 
leading to and from the thorax were ligated and cut. Animals were killed by an 
overdose of sodium pentobarbitone solution (160mg/kg i.v.). The descending 
aorta was cannulated and the preparation excised from C1-T12 (on ice). 
Hearts were retrogradely perfused with an oxygenated Krebs-Hensleit buffer, 
containing (in mM): NaCl 114, KCl 4, CaCl 1.8, NaHCO3 24, MgSO4 1, 
NaH2PO4 1.1, glucose 11.0 and sodium pyruvate 1.0. Perfusion rate was set 
to give an aortic pressure of 70-80mmHg. The right vagus nerve was isolated 
from the surrounding tissues and placed on silver bipolar stimulating 
electrodes connected to a constant voltage stimulator (DS2A, Digitimer, UK).  
 
2.3 Experimental protocols 
All hearts were instrumented for recording of a pseudo bipolar 
electrocardiogram (low pass=100Hz, high pass=0.3Hz, sampling=1KHz) and 
monophasic action potential from the left ventricular free wall (low 
pass=100Hz, high pass=0.3Hz, sampling=1kHz). Hearts were perfused with 
clofilium tosylate (100nmol/L in DMSO) for 20-minutes prior to the 
commencement of the experimental protocols and throughout the study. 
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100nmol/L clofilium was sufficient to cause substantive QT p rolongation 
without AV-block, which can occur with higher concentrations of class III anti-
arrhythmic agents.  
 
2.3.1 Protocol 1 (Sustained noradrenaline) 
Cardiac responses to VNS were assessed at 2, 5, 10 and 20Hz 
stimulation [pulse width=1ms, amplitude=10V, duration=2 minutes per 
frequency] in the absence and presence of 100nmol/L noradrenaline 
(+50M ascorbate). This represents a submaximal concentration in the 
rabbit heart and produces a marked and sustained chronotropic and 
electrophysiological action. Noradrenaline was perfused for a minimum 
of 10-minutes prior to nerve stimulation.  
 
2.3.1 Protocol 2 (Bolus noradrenaline) 
Noradrenaline (0.1ml of 1mM stock) was injected directly into the 
bubble trap of the perfusion apparatus at intrinsic heart rates and 
following 2-minutes of VNS at 5 and 10Hz. Hearts were allowed to 
recover for 10-minutes between injections. 
 
2.4 Blinding and randomisation 
To reduced inter-operator variability, studies were conducted and analysed by 
a single experimenter. The sequence of experimental protocols and order of 
stimulations in Protocols 1 and 2 were randomised prior to the study. The 
nature of the paired study design prevented blinding of the experimenter to 
the study protocols. 
 
2.5 Data analysis 
Experiments were ranked per the severity of observed arrhythmia, using a 
predefined arrhythmia score (no arrhythmia=1, early afterdepolarisations 
(EADs)=2, ventricular tachycardia (VT)=3, sustained VT (>20secs) or 
ventricular fibrillation=4). Note that this is a simple hierarchical scoring 
system, in which the absolute score at each level is not a true quantification of 
arrhythmia severity. Curtis and Walker have previously shown the validity of 
such hierarchical systems for use in arrhythmia quantification.[15] EADs were 
assessed first in monophasic action potential recordings and then confirmed 
in ECG recordings - evidenced by an R-T ectopic in the latter and a premature 
beat occurring before repolarisation of the preceding action potential in MAP 
recordings. Because TdP can present monomorphic or polymorphic patterns 
in ECG recordings from the same subject, depending on the relative angle of 
the recording electrode, presented values are the number of episodes of VT. 
In most cases, ECG and monophasic action potential parameters were 
assessed from 10-beat averages of normally conducted beats. Monophasic 
action potential duration was assessed at 90% repolarisation (MAPD90). 
Action potential triangulation was calculated as MAPD90-MAPD30. 
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2.6 Statistics 
Arrhythmia scores were compared by Wilcoxon’s matched-groups signed 
rank-sum tests. For electrophysiological parameters, parametric statistical 
analyses were applied on the basis that the distribution of the QT interval is 
Gaussian and on the assumption that other electrogram parameters and 
related measures (e.g. action potential triangulation) are similarly distributed.  
Statistical comparisons were made using paired Student’s t-tests and 
repeated measures one or two-way ANOVA with Sidak’s post-hoc tests, as 
appropriate. p<0.05 was considered significant. Continuous variables are 
presented as means (standard deviation (SD)).  
 
3. Results 
3.1 VNS is a trigger for EADs and VT in LQTS 
 
The effects of combined cloflium-treatment and VNS on the incidence of 
spontaneous EAD and VT in rabbit hearts are presented in Figure 1. 
Perfusion of clofi lium (100nmol/L) caused a marked slowing of intrinsic heart 
rate from 203±33 to 164±29 beats per minute (p<0.001) and prolongation of 
the QT interval (270±34 vs. 177±4 ms, p<0.001), but was not associated with 
spontaneous ventricular arrhythmia. Meanwhile, EADs and TdP were readily 
triggered by electrical stimulation of the vagus nerve in clofilium treated rabbit 
hearts. This can be seen in the representative trace in Figure 1A, showing a 
stimulation frequency-dependent slowing of heart rate and the triggering of 
EADs with high intensity stimulation (20Hz). VNS did not induce ventricular 
arrhythmia in the absence of cloflium (data not shown). Data presented on the 
left of Figure 1B&C summarise the incidence of arrhythmia with VNS in 11 
experiments, and show that VNS acted as a stimulation frequency-dependent 
trigger for spontaneous EADs and VT in LQTS; with no arrhythmia observed 
in baseline conditions (i.e. in hearts beating at their intrinsic rate). The 
percentage of hearts exhibiting EADs increased from 0% at baseline to 73% 
with 20Hz VNS, and the maximum incidence of spontaneous VT was 55%. 
Neither EADs or spontaneous VT were observed with VNS before clofilium 
perfusion (data not shown). Arrhythmia were suppressed by the restoration of 
normal beating rates, either spontaneously or by short-term ventricular pacing 
(after which hearts returned to sinus rhythm) (see Figure 2). The pro-
arrhythmic action of VNS is most likely attributed to changes in rate, and not 
due to direct effect on the ventricles, as VNS-triggered EADs and VT were 
abolished by short term ventricular pacing (~1 minute, Figure 2). Furthermore, 
VNS mediated QT prolongation was completely abolished by ventricular 
pacing (see Supplementary Figure 1), indicating that changes in rate are 
essential to the ventricular action of the vagus nerve in the rabbit heart (data 
from untreated hearts). 
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3.2 T-wave duration and action potential triangulation predict EADs during 
VNS 
 
Table 1 presents a comparison of electrophysiological parameters in hearts 
with and without spontaneous EADs during VNS (5Hz) and shows that the 
duration of the T-wave (TpTe interval), a measure of ventricular dispersion of 
repolarisation, and triangulation of the ventricular action potential, are the best 
predictors of VNS-associated triggered activity. EADs were not predicted by 
the RR interval, QT interval, APD and beat-to-beat variability in APD (as 
assessed from 10 sequential beats immediately before the first EAD or the 
last 10-beats before the cessation of VNS). 
  
3.3 Sustained noradrenaline perfusion supresses long QT associated 
arrhythmia 
In the presence of sustained (steady-state) noradrenaline, the propensity for 
EADs and VT with VNS was substantially reduced (Figure 1B&C). With VNS 
at 20Hz, 73% of hearts exhibited EADs in control conditions, compared to 
only 45% in the presence of noradrenaline. TdP exhibited a similar pattern, 
with an incidence of 55% in control conditions vs. 27% during noradrenaline 
perfusion. The average arrhythmia score, a measure of the severity of 
observed arrhythmia, was reduced by sustained noradrenaline perfusion 
(Figure 1D&E). 
 
3.4 VNS antagonises the action of catecholamines on heart rate but not on 
ventricular electrophysiology 
 
The electrophysiological consequences of sustained (steady-state) 
noradrenaline perfusion are presented in Figure 3. As expected, 
noradrenaline perfusion resulted in an increase in heart rate and shortening of 
the QT interval, as well as a reduction in the magnitude of action potential 
triangulation. In the presence of noradrenaline, VNS slowed heart rate to a 
greater degree than that observed in control conditions. At baseline, and with 
low intensity VNS (2Hz), heart rate was elevated by noradrenaline, but this 
effect was lost with at higher intensities of stimulation (Figure 3B) - showing 
that the vagus nerve antagonises the action of noradrenaline on heart rate. By 
comparison, adrenergic-dependent shortening of the QT interval was not 
reversed by VNS (Figure 3C). In fact, the magnitude of VNS-dependent QT 
prolongation was less in the presence of catecholamines (68±5ms vs. 
127±14ms, p=0.003) and thus QT interval was substantially shorter at all 
frequencies of nerve stimulation, despite a similar underlying heart rate  during 
high intensity VNS (see Figure 3C). Similarly, a greater increase in ventricular 
dispersion of repolarisation (as indicated by prolongation of the TpTe interval) 
and triangulation of the action potential was observed with VNS in the 
absence of adrenergic stimulation (Figure 3D&E). The TpTe interval 
increased by 136±34% with VNS alone and 64±22% with VNS and 
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noradrenaline perfusion (p=0.004). Action potential triangulation increased by 
70±16ms with VNS in control conditions vs. 28±9ms with VNS in the presence 
noradrenaline (p=0.003). Taken together, this suggests that VNS does not 
antagonise the electrophysiological action of exogenous noradrenaline in the 
rabbit ventricle, whilst accentuated antagonism is evident in changes in heart 
rate. This likely reflects the greater influence of the parasympathetic nervous 
system at the sinoatrial node vs. the ventricular myocardium. The anti-
arrhythmic action of sustained noradrenaline perfusion in LQTS may be 
attributed to the relative shorter ventricular action potential and reduced action 
potential triangulation during combined autonomic stimulation, which prevents 
EADs. This action may be mediated by rate-dependent or rate-independent 
mechanisms, whereby the action potential intrinsically shortens at faster 
beating rates (a consequence of the kinetic properties of several ion channels 
and alterations in the concentration of intracellular Ca and Na ions), and 
because of increased outward current via the slow delayed rectifying K 
currents (via protein kinase A-dependent phosphorylation of the channel 
subunits). Our data suggest that rate-independent shortening of the 
ventricular action potential is the major mechanism mediating the anti -
arrhythmic action of sustained noradrenaline perfusion, because with high 
intensity VNS there was no difference* in heart rate between VNS alone and 
VNS plus noradrenaline (Figure 3B), but QT interval and APD were 
substantially shorter with combined stimulation at all levels of VNS (Figures 
3C). [A trend is observed, possibly indicating a lack of statistical power to 
detect small differences between groups]. 
 
3.5 Bolus noradrenaline facilitates and exacerbates arrhythmia associated 
with QT prolongation 
 
Electrical pickup on the ECG recordings during direct sympathetic nerve 
stimulation prevents accurate assessment of arrhythmia in the isolated 
innervated rabbit heart. However, rapid infusion of noradrenaline appears to 
be a good correlate of sympathetic nerve stimulation. Supplementary Figure 2 
shows the heart rate response to bolus noradrenaline compared with 
moderate intensity sympathetic nerve stimulation (10Hz, 40V, 2ms pulse 
duration) in the isolated rabbit heart. The presented data show that the initial 
heart rate response to noradrenaline is marginally slower than that of direct 
nerve stimulation (owing to perfusion delay), however, the maximum heart 
rate and time to peak heart rate response was similar between conditions.  
 
Data from 12 experiments on the influence of sudden adrenergic stress on the 
incidence of LQTS associated arrhythmia are presented in Figure 4.  Injection 
of a bolus of noradrenaline into the perfusion line acted in a bi-phasic manner- 
first increasing the risk of arrhythmia in the 10 to 20 second period 
immediately after injection and then acting to accelerate the underlying heart 
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rate, suppressing arrhythmic events. In stage 1, bolus noradrenaline acted to 
increase the severity of the observed arrhythmia, with a dependence on the 
underlying conditions. For instance, noradrenaline commonly triggered EADs 
in the absence of pre-existing arrhythmia or caused VT in hearts already 
exhibiting ectopic activity. As such, VT was more commonly observed with 
noradrenaline perfusion during high intensities of VNS. In two of twelve 
hearts, bolus noradrenaline led to periods of sustained VT (>20secs), which in 
one case degenerated into ventricular fibrillation (VF). The incidence of 
spontaneous EADs, VT and sustained VT/VF with VNS and VNS plus bolus 
noradrenaline are presented in Figure 4B-D. 67% of hearts exhibited 
spontaneous VT with VNS + bolus noradrenaline vs. 33% with VNS alone. 
Spontaneous EADs were observed in just 1 heart following noradrenaline 
perfusion in the absence of VNS. The severity of arrhythmic events was 
increased by combined stimulation, over VNS alone, as evidenced by an 
increase in the average arrhythmia score (Figure 4E&F).  
 
3.6 Bolus noradrenaline causes a transient increase in action potential 
duration and triangulation 
 
To investigate the impact of sudden adrenergic stress on ventricular 
electrophysiology in LQTS we analysed changes in electrophysiological 
parameters following the injection of a bolus of noradrenaline in baseline 
conditions (i.e. in the absence of VNS). This was necessitated by the high 
incidence of arrhythmia during combined autonomic stimulation. These data 
are presented in Figure 5. Bolus noradrenaline caused a rapid increase in 
heart rate that recovered to baseline over a 10-minute period (Figure 5A). A 
transient increase in the duration of the QT interval, ventricular MAPD90 and 
magnitude of action potential triangulation was observed within approximately 
10-seconds of noradrenaline injection; followed by a sustained shortening of 
ventricular repolarisation and reduction of action potential triangulation (Figure 
5B-D). This suggests that application of sudden adrenergic stress in LQTS 
leads to transient pro-arrhythmogenic alterations in ventricular 
electrophysiology. Indeed, the time course of changes in ventricular 
repolarisation paralleled the increase in the risk of arrhythmic events 
immediately following noradrenaline perfusion (during VNS), as well as the 
suppression of said arrhythmia with sustained adrenergic activation. 
Dispersion of repolarisation, as assessed from the duration of the TpTe 
interval, was similar at all time points (Figure 5E). No overall difference in 
beat-to-beat variability for QT interval or APD was observed at any time point 
(data not shown). 
 
4. Discussion 
To our knowledge, this is the first study to show the importance of dynamic 
interplay between the two branches of the autonomic nervous system in 
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LQTS-associated arrhythmogenesis. Our results show that combined 
adrenergic and parasympathetic stimulation has a complex relationship with 
arrhythmogenicity in LQTS. Whilst sustained (steady-state) noradrenaline 
perfusion suppresses the pro-arrhythmic action of VNS, application of a 
sudden adrenergic stressor during a period of sustained parasympathetic 
activation acts to increase the severity of observed arrhythmia. Noradrenaline 
rarely triggers spontaneous VT (1/12 hearts) in the absence of VNS, 
suggesting that concomitant autonomic activation (or “autonomic conflict” ) is 
required for the adrenergic facilitation of LQTS-associated arrhythmia. 
Importantly, this observation parallels the clinical profile for patients with 
congenital LQTS type 2, who commonly die when awoken suddenly by an 
alarm clock - suggesting that they experience lethal arrhythmia when a surge 
in sympathetic / adrenergic activity is superimposed during a time of high 
parasympathetic tone (i.e. during rest or sleep).[10, 13] By recapitulating 
LQTS type II using drugs that block IKr, we show that the number and severity 
of arrhythmia observed with VNS alone is exacerbated by application of 
adrenergic stressor during sustained parasympathetic stimulation. Thus, the 
facilitation of arrhythmogenesis in LQTS by adrenergic stress is critically 
dependent upon the timing and sequence of autonomic stimulation. This 
dependence on the sequence of events likely contributes to the stochastic 
nature of arrhythmia and the difficulties in predicting any individual’s risk of 
sudden death or the timing of that death.  
 
Most of studies on the influence on adrenergic activation on cardiac 
electrophysiology have focussed on steady-state responses and there has 
been only limited investigation into the importance of dynamic changes in 
autonomic tone in LQTS. In studies in the isolated ventricular wedge 
preparation, Schimizu et al. reported that in LQTS type 2, noradrenaline 
perfusion leads to a transient increase in transmural dispersion of 
repolarisation.[16] The authors showed that increased repolarisation 
heterogeneity correlated with an increase in the susceptibility to spontaneous 
and electrically induced VT. In our analysis of T-wave duration we found no 
evidence that adrenergic stress results in an increase in dispersion of 
repolarisation in the rabbit ventricles, but observed a transient increase in 
action potential duration and triangulation. The rate of repolarisation is thought 
to be an important factor in the generation of EADs, as this may lead to the 
reactivation of the inward calcium current and the reversal of membrane 
potential - either directly via inward current through the L -type calcium 
channels or due to stimulated release of calcium from the sarcoplasmic 
reticulum.[17-19] Thus, the increase in action potential triangulation with 
sudden adrenergic stress combined with parasympathetic acti vation may 
facilitate EADs and explain the transient increase in risk of arrhythmia with 
concomitant autonomic stimulation. Notably, recurrent ectopic activity is one 
mechanism thought to underpin TdP and is a feasible mechanism for the 
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increased incidence of VT observed during bolus noradrenaline injections.[20] 
Our observations parallel a report by Liu et al., who demonstrated a transient 
risk for EADs in isolated myocytes from rabbits with congenital LQTS type 2 
on exposure to isoprenaline - attributed to differential kinetics for activation of 
the L-type calcium current and slow component of the delayed rectifying 
potassium current.[21] A similar kinetic mismatch in the targets for protein 
kinase A dependent phosphorylation was predicted by integrated 
computational modelling of calcium and beta-adrenergic signalling.[22] 
Interestingly, in a follow up study, Xie et al. predicted that that sudden 
adrenergic stress favours the transition from VT to VF, due to dynamic 
changes in APD restitution, which may have relevance to our observation that 
bolus noradrenaline is associated with a transient risk of more severe 
tachyarrhythmia.[23] Faster onset kinetics of the L-type calcium current may 
explain the transient increase in action potential duration, triangulation and 
incidence of VT with bolus noradrenaline perfusion in our study. With more 
sustained adrenergic stimulation, the current carried by IKs is increased, acting 
to shorten the action potential and to reduce the risk of further ectopic activity. 
The same mechanism could explain why sustained adrenergic stimulation 
acts to suppress arrhythmia. Indeed, loss-of-function mutations in the pore-
forming subunits of channels that conduct IKs are the most common form of 
congenital LQTS. In this scenario, IKs  is weaker and does not counteract the 
increase in L-type current during adrenergic-stimulation, promoting EADs. 
Another factor in the suppression of LQTS-associated arrhythmia by 
sustained adrenergic stimulation is the resulting acceleration of heart rate, 
which shortens the action potential, secondary to changes in the 
concentration of intracellular ions, including, Na and Ca. Bradycardia is a well-
established trigger for drug-induced LQTS-related arrhythmia and tachypacing 
can prevent sudden death both acutely and as a long-term therapy.[24, 25] 
 
That VNS is an independent trigger for arrhythmia in drug-induced LQTS is 
not surprising and is in keeping with existing clinical and experimental 
evidence. Bradycardia is a well-established risk factor for TdP and Farkas et 
al. previously demonstrated that the induction of TdP in the phenylephrine-
sensitised rabbit is dependent upon activation of the parasympathetic nervous 
system.[26] Phenylephrine, a selective alpha1-adrenoceptor agonist, 
increases blood pressure and activates the baroreceptor reflex, leading to a 
slowing of heart rate via the vagus nerve. In our study, VNS causes 
prolongation and triangulation of the ventricular action potential, which likely 
underpins the pro-arrhythmogenic action of parasympathetic activation in 
LQTS. It is notable that one of the best correlates of ectopic activity following 
VNS was the TpTe interval, a measure of dispersion of repolarisation. This 
observation could indicate the requirement for a critical gradient of 
repolarisation in order that ectopic beats can propagate through the 
ventricular myocardium. Alternatively, the TpTe interval may simply reflect the 
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development of islands of tissue with prolonged APD from where ectopic 
activity first arises.[27] Furthermore, increased dispersion of repolarisation is a 
substrate that favours re-entrant arrhythmia and may predispose to TdP, in 
keeping with our previous observations.[28] 
 
Beta-adrenoceptor antagonists are the first line therapy for congenital LQTS, 
with an efficacy that is determined by the molecular basis of QT-prolongation. 
Beta-adrenoceptor blockade is reported to be most effective in LQTS type 1 
and only moderately effective in LQTS type 2 and LQTS type 3.[10] On this 
basis, we propose that the partial effectiveness of beta-blockade in congenital 
LQTS type 2 reflects that arrhythmia can be triggered by parasympathetic 
activation alone, but that the incidence and severity of arrhythmia is increased 
by sudden adrenergic stress. Beta-blockade likely inhibits the latter case, but 
clearly this does not entirely abolish the risk of TdP in this patient population. 
Many useful therapeutic drugs, including antipsychotics and antiarrhythmics, 
also cause QT prolongation and carry risk of TdP and sudden cardiac death 
[29]. Where the risk-to-benefit ratio is high, QT-prolonging drugs should be 
withdrawn in patients exhibiting excessive QT prolongation or symptoms of 
LQTS (e.g. dizziness, syncope). However, when the risk to benefit ratio is low 
(i.e. low-risk, high-benefit), our data suggest that patients could benefit from 
prophylactic beta-adrenoceptor blockade. That is to say, beta-blockade may 
be an effective strategy to mitigate risk of sudden death in drug-induced 
LQTS, in addition to congenital forms, and where there is no alternative to use 
of QT-prolonging drugs. Symptoms of syncope and the risk of sudden death 
in patients with congenital LQTS who are refractory to beta-blockade can also 
be mitigated by left sympathetic denervation, a surgical procedure that 
involves ablation of left stellate ganglion; the major source of sympathetic 
efferent nerve fibres that innervate the ventricles. Schwartz et al. have 
previously shown the efficacy of this approach in patients with congenital 
LQTS who continue with symptoms of syncope or cardiac arrest despite beta -
blocker therapy.[30] With type 2 LQTS, where bradycardia is an independent 
trigger for arrhythmia, further benefits could be provided by the combined use 
of beta-blockers/denervation and chronic atrial pacing.[25] 
 
We have previously suggested that autonomic conflict, the simultaneous 
activation of the sympathetic and parasympathetic inputs to the heart, might 
be an arrhythmogenic trigger.[3] The basis for this is observations of 
substantive cardiac dysrhythmia and arrhythmia in young healthy adults within 
the first minute of submersion in cold-water; a potent stimulator of the 
sympathetically driven cold-water shock response and parasympathetcally 
mediated mammalian diving reflex. Importantly, similar events are not 
commonly observed in the same participants during head out cold-water 
immersion, or with facial immersion alone, suggesting that autonomic co -
activation plays a critical role. We recently reported that combined autonomic 
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stimulation (i.e. sustained noradrenaline + VNS) is insufficient to cause 
significant arrhythmia in healthy isolated rabbit hearts.[31] However, we show 
presently that concomitant stimulation can trigger severe arrhythmia in the 
presence of a predisposing electrophysiological abnormality, and in a manner, 
that is critically dependent on the timing of the adrenergic stimulus. Autonomic 
conflict may also have broader importance in other forms of LQTS, for 
example, it may explain why swimming is a gene-specific trigger for TdP and 
sudden death in congenital LQTS type 1.[9] Moreover, dynamic events, 
leading to sudden alterations in autonomic tone, are likely to be an important 
contributing factor in many arrhythmogenic syndromes and pre-disposing 
conditions. For example, swimming may be a trigger for arrhythmia in patients 
with genetic mutations associated with catecholinergic polymorphic ventricular 
tachycardia.[11] Greater understanding of how the dynamic changes in 
autonomic tone influence electrophysiology and arrhythmogensis in disease 
may be an important factor in the development of more effective therapeutic 
strategies for the management of sudden cardiac death. 
 
Animal models of TdP are essential for studies of the arrhythmogenic 
processes in LQTS, and also have utility for safety screening of QT prolonging 
drugs, however, there are several limitations with existing experimental 
approaches. These include: the necessary use of anaesthetic agents in in 
vivo models,[26] a failure to predict the pro-arrhythmic potential of recognised 
torsadegenic drugs,[26] use of non-physiological conditions (e.g. perfusion of 
acetylcholine to mimic VNS), a reliance on expensive protocols (e.g. chronic 
atrioventricular block in the dog),[32] and the low incidence of TdP in the 
absence of electrical induction protocols.[16] In this study, we describe a 
novel protocol that recapitulates LQTS-associated arrhythmogenesis, 
including spontaneous EADs and VT. With concomitant autonomic stimulation 
(VNS + bolus noradrenaline) the maximum incidence of EADs and VT in our 
study was 92% and 67%, respectively. As such, the innervated rabbit heart 
may be a useful model for the study of LQTS-associated arrhythmia. This 
approach has several potential advantages over existing models, including; 
the preservation of natural cardiac activation and repolarisation patterns, the 
ability to perform repeat measurements in the same heart, no requirement for 
anaesthetic agents, that heart rate can be altered physiologically by direct 
nerve stimulation and great flexibility / adaptability (e.g. rapid washout of 
drugs, altered ionic composition). Moreover, the model is relatively low-cost 
and requires only minimal training to implement. This facility of the ex vivo 
innervated heart in drug safety screening will require extensive validation and 
is a focus for future work.  
 
4.1 Limitations 
There are several limitations that deserve discussion. Firstly, in preliminary 
experiments we found that direct sympathetic nerve stimulation caused 
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significant electrical pickup on ECG recordings, making it difficult to accurately 
determine the onset and type of arrhythmia. For this reason, we used 
exogenously perfused noradrenaline to mimic the effects of nerve stimulation. 
For the same reason, we are unable to compare the electrophysiological 
responses to noradrenaline and SNS in our experimental model, and so 
cannot conclude as to how similar bolus noradrenaline is to the traditional 
“fight or flight” response, which is likely mediated by local neurotransmitter 
release. Further studies, uti lising techniques such as optical mapping, which 
do not suffer from electrical interference, could be used to address this 
limitation and to dissect out the underlying cellular mechanisms.  
Secondly, both ketamine and medetomidine can influence autonomic 
control. However, as experiments were performed in an in vitro preparation, 
with significant time for drug washout, we believe this is unlikely to influence 
our results. Moreover, nerve responses were robust and reproducible 
throughout the experimental protocols.  
Thirdly, the incidence of VT at baseline between protocols 1 and 2 was 
modestly different (2 vs. 4 episodes), which could simply reflect  that more 
extended periods of VNS (as in protocol 1) are associated with a higher 
incidence of spontaneous arrhythmia. However, given that difference between 
the groups is not statistically significant, this observation may simply be down 
to chance. 
Fourthly, on the slowing of heart rate with VNS, it was common for map 
recordings to exhibit unstable diastolic potentials (when previously stable at 
baseline), which was likely attributed to slight movement of the recording 
electrode secondary to altered contractile motion of the heart. This can be 
seen in the example trace shown in Figure 1A. To avoid mechanical triggering 
of arrhythmia, we opted not to re-orientate the electrode mid protocol. 
However, despite the observed instability, it was sti ll possible to accurately 
detect the onset of EADs, particularly as our analysis relied on concomitant 
observations in MAP recordings and in the ECG. Fifthly, we employed 
unilateral right-sided VNS and so cannot conclude whether our findings also 
apply to left or bilateral stimulation protocols. However, previous studies 
indicate that there is no difference in the chronotropic and electrophysiological 
effects of left and right-sided VNS in pigs, which corroborates unpublished 
observations from our laboratory (in rabbits).[33]  
Finally, clofi lium is an K channel blocker with a similar IC50 to E4031 and 
dofetilide, and has proven efficacy for the induction of TdP in rabbits.[34]  The 
purpose of the present study was to develop a model that replicates 
congenital LQTS and not necessarily to compare directly to clinically used (or 
historical) pharmaceutical agents (e.g. d-sotalol, dofeti lide). Whilst alternative 
class III agents are more commonly employed in experimental studies, many 
K channel blockers exhibit similar potency and we do not believe that our use 
of clofilium detracts from the conclusions of the present study.[34] Moreover, 
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we have previously shown that VNS can trigger TdP in rabbit hearts treated 
with E4031, a result replicated presently with clofilium.[28]   
 
5. Conclusions 
Autonomic conflict, the simultaneous activation of parasympathetic and 
sympathetic autonomic inputs to the heart, can facilitate arrhythmogenesis in 
LQTS. Dynamic alterations in autonomic tone may be an important 
contributory factor in many arrhythmogenic syndromes or in conditions that 
predispose to ventricular arrhythmia. 
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Figure 1. Sustained noradrenaline perfusion suppresses LQTS 
associated arrhythmia. A) Representative traces demonstrating the slowing 
of heart rate with increasing intensities of vagus nerve stimulation (VNS)  in a 
clofilium-treated (100nmol/L) rabbit heart. In this example, early 
afterdepolarisations (EADs) are triggered at 20Hz VNS. B&C) Arrhythmia 
counts for 11-experiments demonstrating a reduction in the incidence of EADs 
and ventricular tachycardia (VT) with sustained noradrenaline (NA, 
100nmol/L) perfusion. D&E) Individual and average (Tukey’s box plot) 
arrhythmia scores during VNS and with VNS+NA (sustained). Different from 
VNS alone; *p<0.05. Comparisons by Wilcoxon’s matched-groups signed 
rank-sum test (n=11 hearts). 
 
Figure 2. Suppression of VNS triggered arrhythmia by rapid pacing. 
Representative traces showing spontaneous episodes of early 
afterdepolarisations and ventricular tachycardia following vagus nerve 
stimulation (VNS), with subsequent rapid ventricular pacing (cycle 
length=190ms) and on the cessation of pacing (following 1-minute of 
sustained pacing).  
 
Figure 3. Electrophysiological changes during VNS with and without 
sustained noradrenaline. A) Representative traces demonstrating changes 
in electrocardiogram (ECG) parameters during VNS in a clofilium-treated 
(100nmol/L) rabbit heart, with and without sustained noradrenaline (NA, 
100nmol/L) perfusion. B-E) Average values on the change in heart rate, QT 
interval, T-wave peak to end interval (TpTe) and monophasic action potential 
(MAP) triangulation. Data represent mean (SD). Different from clofilium 
(control); *p<0.05. Two-way repeated measures ANOVA, with Sidak’s post-
hoc tests (n=7 hearts).  
 
Figure 4. Bolus noradrenaline facilitates LQTS associated arrhythmia. A) 
Representative episodes of spontaneous ventricular tachycardia (VT) in a 
clofilium-treated (100nmol/L) rabbit heart. The left trace was observed during 
VNS and the right following bolus noradrenaline (NA) perfusion (0.1ml of 1mM 
stock), in separate experiments. B-D) Arrhythmia counts for 12-experiments, 
demonstrating an increase in the incidence of early aftedepolarizations 
(EADs), VT and sustained VT (VTsus)/ventricular fibrillation (VF) with VNS + 
NA (bolus). E&F) Individual and average arrhythmia scores during VNS and 
with VNS+NA (bolus). Different from VNS alone; *p<0.05. Comparisons  by 
Wilcoxon’s matched-groups signed rank-sum test (n=12 hearts). 
 
Figure 5. Electrophysiological effects of bolus noradrenaline in LQTS. A) 
Experimental trace demonstrating the change in heart rate and monophasic 
action potential duration (MAPD90) following bolus noradrenaline (NA) 
perfusion (0.1ml of 1mM stock) in a clofilium treated (100nmol/L) rabbit heart. 
A transient increase in MAPD90 is seen immediately following NA perfusion. 
Inset are representative action potential recordings from the time points  noted 
by []. B-E) Average values for QT interval, T-wave peak to end interval 
(TpTe), MAPD90 and action potential triangulation at baseline, at peak 
response and at 30-seconds post-peak response. Data represent mean (SD). 
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Different from baseline; *p<0.05. Comparisons by one-way ANOVA, with 
Sidak’s post-hoc tests (n=9 hearts). 
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Table 1. Electrophysiological predictors of early afterdepolarisations. 
 
Comparison of electrocardiogram and monophasic action potential 
parameters in hearts with and without early afterdepolarisations (EADs) 
during vagus nerve stimulation (VNS) at 5Hz. 10-beat averages immediately 
before the first EAD or the last 10-beats before the cessation of VNS. 
BBV=beat-to-beat variability. Data represent means (SD). Comparisons by 
unpaired Student’s t-tests. *p<0.05 (n=6 per group). 
 
 
 
 
  
Parameters Experiments 
without EADs 
Experiments 
with EADs 
P value 
RR interval (ms) 465 (98) 560 (105) 0.139 
QT Interval (ms) 335 (38) 382 (50) 0.098 
TpTe Interval (ms) 59 (10) 99 (21) *0.001 
APD90 (ms) 261 (26) 285 (42) 0.176 
APD BBV (ms) 2.8 (3.9) 12.3 (24.0) 0.364 
Action potential 
triangulation (ms) 
125 (17) 164 (39) *0.045 
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Highlights 
 Long QT syndrome associated arrhythmia were studied with dual 
autonomic stimulation  
 EADs and TdP were triggered by increased vagal tone 
 Sudden adrenergic stress increased the severity of observed 
arrhythmia 
 Arrhythmia were prevented by sustained adrenergic stimulation 
 The sequence of autonomic stimulation influences the severity of 
long QT arrhythmia 
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